KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice

article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-07

Concomitant KRAS mutation and p53 loss in mouse ovarian surface epithelium induces metastatic ovarian carcinosarcomas that recapitulate human disease histomorphology and malignant transformation mechanisms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Ovarian carcinosarcoma cancer is the most lethal form of gynecological malignancy, but the pathogenesis and biological function for this ovarian cancer remain unknown. We establishment the transgenic mouse model of K‐ras G12D p53 loxP/loxP and found that K‐ras mutation and p53 deletion within the ovarian surface epithelium gave rise to ovarian lesions with a hyperproliferation and endometrioid glandular morphology. Furthermore, double mutant ovaries formed ovarian carcinosarcomas that were high grade and poorly differentiated. Induction was widely metastatic and spread to abdominal organs including liver, spleen, and kidney at 4 wk. We also confirmed the role of K‐ras G12D in ovarian cancer cell lines MCAS and PA‐1 and showed that K‐ras G12D overexpression strongly induced cell proliferation, migration, and invasion. The ovarian cancer model we developed recapitulates the specific tumor histomorphology and the probable mechanism of malignant transformation in endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Carcinosarcoma Ovarian Neoplasms Proto-Oncogene Proteins p21(ras) Tumor Suppressor Protein p53 Animals Carcinosarcoma Carcinosarcoma Cell Line, Tumor Cell Proliferation Cell Proliferation Cell Transformation, Neoplastic Cell Transformation, Neoplastic Disease Models, Animal Female Humans Mice Mice, Transgenic Mutation Ovarian Neoplasms Ovarian Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (43)

Cited by (5)

Source provenance

europepmc
last seen: 2026-08-17T06:11:01.428247+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:20:37.704673+00:00
License: CC0 · commercial use OK